| Insider Name | Buy/Sell | Company Name | Ticker | Amount | Shares Change | |||
|---|---|---|---|---|---|---|---|---|
| Apr 03, 2025 | Sell | $4.15 | $11,126 | -0.76% | ||||
| May 15, 2024 | Buy | $6.26 | $475,760 | +18.16% | ||||
| Dec 06, 2021 |
| Buy |
| Verve Therapeutics, Inc. | VERV |
| $32.1 |
| $128,420 |
| +2.29% |
| Aug 03, 2015 | Aug 05, 2015 | Ashe Andrew D. GC EVP | Sell | Dyax Corp | DYAX | $24.21 | $2M | -64.62% |
| Mar 06, 2015 | Mar 06, 2015 | Ashe Andrew D. GC EVP | Sell | Dyax Corp | DYAX | $15.5 | $37,200 | -6.57% |
| Feb 26, 2015 | Feb 26, 2015 | Ashe Andrew D. GC EVP | Sell | Dyax Corp | DYAX | $15.34 | $23,010 | -3.94% |
| Mar 03, 2014 | Mar 04, 2014 | Ashe Andrew D. GC EVP | Sell | Dyax Corp | DYAX | $10 | $300,000 | -45.26% |
| Feb 26, 2014 | Feb 26, 2014 | Ashe Andrew D. GC SVP Adm. | Sell | Dyax Corp | DYAX | $10.1 | $27,502 | -18.15% |
| Aug 13, 2013 | Aug 15, 2013 | Ashe Andrew D. GC SVP Adm. | Sell | Dyax Corp | DYAX | $4.3 | $139,750 | -68.42% |